Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00799604 · ClinicalTrials.gov registry record · Phase 2
Clevidipine Bolus Administration in the Treatment of Hypertensive Patients Undergoing Cardiac Surgery (SPRINT)
A Phase 2 study, sponsored by The Medicines Company.
- Completed
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
NCT00799604 is a Phase 2 study that has completed, run by The Medicines Company. The registered enrollment target is 30 participants.
The verdict
NCT00799604, a Phase 2 study, has completed, sponsored by The Medicines Company.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study was designed to evaluate the pharmacodynamics of a bolus dosing regimen of clevidipine, a vascular-selective L-type calcium channel antagonist, for the management of blood pressure in cardiac surgery patients, as well as to evaluate the efficacy, safety and pharmacokinetics of clevidipine after bolus administration.
Interventions
- DRUG clevidipine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2008-11 |
| Est. Completion | 2009-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00799604
The ClinicalTrials.gov registry entry for NCT00799604 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Medicines Company, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which clevidipine is the first listed.
NCT00799604 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00799604 about?
NCT00799604 is a clinical study titled "Clevidipine Bolus Administration in the Treatment of Hypertensive Patients Undergoing Cardiac Surgery (SPRINT)". This study was designed to evaluate the pharmacodynamics of a bolus dosing regimen of clevidipine, a vascular-selective L-type calcium channel antagonist, for the management of blood pressure in cardiac surgery patients, as well as to evaluate the efficacy, safety and pharmacokinetics of clevidipine...
What is the current status of trial NCT00799604?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2008-11. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00799604?
The interventions under investigation include: clevidipine (DRUG).
Who is sponsoring clinical trial NCT00799604?
This trial is sponsored by The Medicines Company, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.